Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» thyroid cancer
thyroid cancer
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
BioSpace
Eli Lilly
Retevmo
thyroid cancer
medullary thyroid cancer
clinical trials
Exelixis
Capometyx
Sanofi
Caprelsa
Flag link:
Novo Nordisk says EMA raised safety signal on drugs including semaglutide
Novo Nordisk says EMA raised safety signal on drugs including semaglutide
Yahoo/Reuters
Novo Nordisk
EMA
semaglutide
Ozempic
Wegovy
thyroid cancer
obesity
diabetes
Flag link:
Exelixis pulls a surprise win in thyroid cancer just days ahead of final Cabometyx readout
Exelixis pulls a surprise win in thyroid cancer just days ahead of final Cabometyx readout
Endpoints
ESMO
Exelixis
thyroid cancer
Cabometyx
Flag link:
ASCO: Exelixis releases more details on Cabometyx thyroid cancer data that wooed Ipsen
ASCO: Exelixis releases more details on Cabometyx thyroid cancer data that wooed Ipsen
Fierce Pharma
ASCO 2021
Ipsen
Exelixis
Cabometyx
thyroid cancer
clinical trials
Flag link:
Exelixis' Cabometyx scores backing from Ipsen in thyroid cancer, with full data release set for ASCO
Exelixis' Cabometyx scores backing from Ipsen in thyroid cancer, with full data release set for ASCO
Fierce Pharma
Exelixis
Cabometyx
Ipsen
thyroid cancer
Flag link:
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
Pharmaforum
Roche
Blueprint Medicines
Gavreto
thyroid cancer
Retevmo
Eli Lilly
Flag link:
Racing Blueprint, Lilly drug gets priority review for RET hopeful
Racing Blueprint, Lilly drug gets priority review for RET hopeful
Fierce Biotech
Eli Lilly
FDA
Blueprint Medicines
selpercatinib
LOXO-292
thyroid cancer
non-small cell lung cancer
Flag link:
AI Mines Clinical Data for Thyroid Cancer Therapeutic Targets
AI Mines Clinical Data for Thyroid Cancer Therapeutic Targets
Medical Devices and Diagnostics Industry
thyroid cancer
artificial intelligence
diagnostics
Predictive Oncology
Interpace Diagnostics
Flag link:
Exelixis Hits Blockbuster Status
Exelixis Hits Blockbuster Status
Motley Fool
Exelixis
cabozantinib
Cabometx
kidney cancer
liver cancer
Cometriq
thyroid cancer
Flag link:
Veracyte Presents Data Demonstrating Afirma's Success in Reducing Unnecessary Surgery
Veracyte Presents Data Demonstrating Afirma's Success in Reducing Unnecessary Surgery
CP Wire
Veracyte
diagnostics
thyroid cancer
thyroid nodules
Flag link:
Veracyte Presents Data Demonstrating Afirma's Success in Reducing Unnecessary Surgery
Veracyte
thyroid cancer
Flag link:
Exelixis Begins Ph III Trial of Cabometyx in Refractory Thyroid Cancer
Exelixis Begins Ph III Trial of Cabometyx in Refractory Thyroid Cancer
CP Wire
Exelixis
Cabometyx
thyroid cancer
Flag link:
Exelixis Begins Ph III Trial of Cabometyx in Refractory Thyroid Cancer
Exelixis
Cabometyx
thyroid cancer
Flag link:
Could a New Imaging Device Curb Thyroid Cancer?
Could a New Imaging Device Curb Thyroid Cancer?
Medical Devices and Diagnostics Industry
AmCad BioMed
thyroid cancer
diagnostics
Flag link:
Eisai's Lenvima posts big growth numbers as Merck collaboration rolls into action
Eisai's Lenvima posts big growth numbers as Merck collaboration rolls into action
Fierce Pharma
Merck
Eisai
Lenvima
kidney cancer
thyroid cancer
Flag link:
AstraZeneca’s selumetinib flops in thyroid cancer, adding to list of failures
AstraZeneca’s selumetinib flops in thyroid cancer, adding to list of failures
Fierce Biotech
AstraZeneca
thyroid cancer
selumetinib
Flag link:
Eisai's launch for 'crown jewel' Lenvima tracking better than execs expected
Eisai's launch for 'crown jewel' Lenvima tracking better than execs expected
Fierce Pharma Marketing
Eisai
Lenvima
thyroid cancer
Flag link:
Eisai Says New Cancer Drug Reaching Patients Faster Than Planned
Eisai Says New Cancer Drug Reaching Patients Faster Than Planned
Bloomberg
Eisai
patients
Lenvima
thyroid cancer
Flag link:
Eisai gets EMA nod for Lenvima just weeks after FDA approval
Eisai gets EMA nod for Lenvima just weeks after FDA approval
Fierce Pharma
Eisai
FDA
Lenvima
thyroid cancer
Flag link:
Can Eisai pump its thyroid cancer pill to $1B in sales? Rival Bayer might object
Can Eisai pump its thyroid cancer pill to $1B in sales? Rival Bayer might object
Fierce Pharma Marketing
Eisai
Bayer
thyroid cancer
Lenvima
Nexavar
Flag link:
Pages
1
2
3
next ›
last »